From: Screening with the double surprise question to predict deterioration and death: an explorative study
SQ1 | DSQ | |||||
---|---|---|---|---|---|---|
Group 1 (SQ1 yes) n = 131a | Group 2 (SQ1 no) n = 161 | Group 1 (SQ1 yes) N = 131a | Group 2a (SQ1 no, SQ2 no) n = 139 | Group 2b (SQ1 no, SQ2 yes) n = 22 | All patients n = 292 | |
Age; mean (sd) | 82 (4.67) | 86 (5.24) | 82 (4.67) | 86 (5.23) | 87 (5.32) | 84 (5.46) |
Gender; female n (%) | 87 (131 (66%) | 88/161 (55%) | 87 (131 (66%) | 77/139 (55%) | 11/22 (50%) | 175/292 (60%) |
Living situation; n (%) | ||||||
-at home | 88/122 (72%) | 91/154 (59%) | 88/122 (72%) | 79/133 (59%) | 12/21 (57%) | 179/276 (65%) |
-residential home | 33/122 (27%) | 61/154 (40%) | 33/122 (27%) | 52/133 (39%) | 9/21 (43%) | 94/271 (34%) |
-with family, other than partner | 1/122 (1%) | 2/154 (1%) | 1/122 (1%) | 2/133 (2%) | 0/21 (0%) | 3/276 (1%) |
Marital status; n (%) | ||||||
-married or living together | 69/124 (56%) | 55/156 (35%) | 69/124 (56%) | 48/135 (36%) | 7/21 (33%) | 124/280 (44%) |
-widow or single | 55/124 (%) | 101/156 (65%) | 55/124 (44%) | 87/135 (64%) | 14/21 (67%) | 156/280 (56%) |
Care provider; n (%) | ||||||
-child | 19/123 (15%) | 65/155 (42%) | 19/123 (15%) | 55/134 (41%) | 10/21 (48%) | 84/278 (30%) |
-partner | 1/123 (1%) | 6/155 (4%) | 1/123 (1%) | 6/134 (5%) | 0/21 (0%) | 7/278 (3%) |
-other | 10/123 (8%) | 18/155 (12%) | 10/123 (8%) | 14/134 (10%) | 4/21 (19%) | 28/278 (10%) |
-unknown or none | 93/123 (76%) | 66/155 (43%) | 93/123 (76%) | 59/134 (44%) | 7/21 (33%) | 159/278 (57%) |
Home care; n (%) | 18/123 (15%) | 83/155 (54%) | 18/123 (15%) | 67/134 (50%) | 16/21 (76%) | 101/278 (36%) |
Diseasesb; n (%) | ||||||
-cancer | 2/123 (2%) | 19/155 (12%) | 2/123 (2%) | 11/134 (8%) | 8/21 (38%) | 21/278 (8%) |
-organ failurec | 24/123 (20%) | 38/155 (25%) | 24/123 (20%) | 67/134 (50%) | 16/21 (76%) | 107/278 (39%) |
-cognitive impairment | 10/123 (8%) | 38/155 (25%) | 10/123 (8%) | 34/134 (25%) | 4/21 (19%) | 48/278 (17%) |
-chronic heart failure | 7/123 (6%) | 23/155 (15%) | 7/123 (6%) | 15/134 (11%) | 8/21 (38%) | 30/278 (11%) |